An abnormal cervicovaginal cytology smear in uterine carcinosarcoma is an adverse prognostic sign: Analysis of 25 cases

American Journal of Clinical Pathology

Volumn 122, Issue 3, 2004, Pages 434-439

  Snyder, Matthew J ^a   Robboy, Stanley J ^a   Vollmer, Robin T ^a,b   Dodd, Leslie G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Carcinosarcoma; Cytology; Malignant mixed mesodermal tumor; Malignant mixed m llerian tumor; MMMT; Papanicolaou smear; Prognosis; Uterus

Indexed keywords

CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CARCINOSARCOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PAPANICOLAOU TEST; PARAMETER; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SPINDLE CELL; SURVIVAL RATE; UTERINE CERVIX CYTOLOGY; UTERUS CARCINOMA; UTERUS CARCINOSARCOMA;

EID: 4344631399     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/KUA1FQ3BQRC8YG4V     Document Type: Review

References (13)

1. Cox DR, Oakes D. Analysis of Survival Data. London, England: Chapman and Hall; 1984. Monographs in Statistics and Applied Probability; vol 21.
2. Costa MJ, Tidd C, Willis D. Cervicovaginal cytology in carcinosarcoma (malignant mixed müllerian [mesodermal] tumor) of the uterus. Diagn Cytopathol. 1992;8:33-40.
3. Massoni EA, Hadju SI. Cytology of primary and metastatic uterine sarcomas. Acta Cytol. 1984;28:93-100.
4. Matsuyama S, Tokunaga T, Mimori H, et al. Exfoliative cytology of mixed mesodermal tumors of the uterus: review of cytologic smears sampled prior to therapy [in Japanese]. Nippon Sanka Fujinka Gakkai Zasshi. 1985;37:1125-1134.
5. Parker JE. Cytologic findings associated with primary uterine malignancies of mixed cell types (malignant mixed müllerian tumor). Acta Cytol. 1964;8:316-320.
6. Tenti, P, Babilonti L, La Fainza A, et al. Cytology of malignant mixed mesodermal tumour of the uterus: experience of 10 cases. Eur J Gynaecol Oncol. 1989;10:125-128.
7. White TH, Glover JS, Peete CH, et al. A 34-year clinical study of uterine sarcoma including experience with chemotherapy. Obstet Gynecol. 1965;25:657-663.
8. An-Foraker SH, Kawada CY. Cytodiagnosis of endometrial mixed mesodermal tumor. Acta Cytol. 1983;29:137-141.
9. Larson DM, Johnson KK, Reyes CN Jr, et al. Prognostic significance of malignant cervical cytology in patients with endometrial cancer. Obstet Gynecol. 1994;84:399-403.
10. Gu M, Shi W, Barakat RR, et al. Pap smears in women with endometrial carcinoma. Acta Cytol. 2001;45:555-560.
11. Guidos BJ, Selvaggi SM. Detection of endometrial adenocarcinoma with the ThinPrep Pap Test. Diagn Cytopathol. 2000;23:260-265.
12. Schorge JO, Hossein Saboorian M, Hynan L, et al. ThinPrep detection of cervical and endometrial adenocarcinoma: a retrospective cohort study. Cancer. 2002;96:338-343.
13. Uyar DS, Eltabbakh GH, Mount SL. Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant. Gynecol Oncol. 2003;89:227-232.